About Glycogen Storage Disease Type Ia
The liver stores sugar as glycogen and releases it as glucose when the body needs fuel between meals. The last step depends on an enzyme called glucose-6-phosphatase, made from the G6PC1 gene. In GSD Ia that enzyme is missing or does not work, so the liver cannot release glucose. Blood sugar falls within a few hours of eating, and the trapped sugar is turned into glycogen and fat that build up in the liver and kidneys. GSD Ib is a related but different condition caused by the SLC37A4 gene, and it often also brings low white blood cell counts and bowel inflammation.
Daily care is built around never letting blood sugar fall: meals every 3 to 4 hours rich in complex carbohydrates, uncooked cornstarch between meals and overnight (often first tried between 6 and 12 months of age), Glycosade, an extended-release cornstarch taken once overnight, and overnight tube feeding for some young children. Families also limit sucrose, fructose and galactose. Over the years people can develop liver adenomas, benign tumors that can turn cancerous, kidney disease, gout and thinning bones, so regular liver scans and kidney checks matter. A liver transplant is considered when adenomas grow or metabolic control is poor.
Common Symptoms of Glycogen Storage Disease Type Ia
Recognizing the signs of Glycogen Storage Disease Type Ia early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.
- Low blood sugar between meals or overnight, which can cause seizures
- A large liver that makes the belly stick out
- Lactic acid buildup in the blood
- High uric acid and high blood fats
- Slow growth and short height, with a round, full-cheeked face
- Nosebleeds or easy bleeding, and diarrhea
Who Glycogen Storage Disease Type Ia Affects
Symptoms usually start at 3 to 4 months of age, when babies begin sleeping longer between feeds. GSD Ia is autosomal recessive: a child is affected when both parents pass on a changed G6PC1 gene, and each child of 2 carrier parents has a 25% chance. With treatment most people live into adulthood, but they need lifelong care for blood sugar, the liver and the kidneys.
Find Your Next Step
Answer a few questions and we'll point you to the right tools and information for where you are right now.
FDA-Approved Treatments for Glycogen Storage Disease Type Ia
There is currently 1 FDA-approved medication for Glycogen Storage Disease Type Ia. These therapies represent the current standard of care and may be used alongside or compared against investigational treatments in active clinical trials.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Help Paying for Glycogen Storage Disease Type Ia Treatment
Charity funds and drugmaker programs for Glycogen Storage Disease Type Ia, checked at the source.
Side Effect Explorer
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Genetic Testing
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Glycogen Storage Disease Type Ia Resources
Reputable organizations and medical references for learning more about Glycogen Storage Disease Type Ia, including disease registries, foundation resources, and clinical guidelines.